Computational Immune Monitoring Reveals Abnormal Double-Negative T Cells Present across Human Tumor Types
Allison R. Greenplate(California University of Pennsylvania), Jonathan M. Irish(Vanderbilt University), Brian K. Oberholtzer(Vanderbilt University), Daniel D. McClanahan(Vanderbilt University), Megan L. Rasmussen(Vanderbilt University), Kirsten E. Diggins(Vanderbilt University), Mark C. Kelley(Vanderbilt University), Douglas B. Johnson(Vanderbilt University Medical Center), Deon B. Doxie(Vanderbilt University), Nalin Leelatian(Yale University), Jeffrey C. Rathmell(University of Chicago), Caroline E. Roe(Vanderbilt University), Peter J. Siska(University Hospital Regensburg), Vivian Gama(Vanderbilt University), P. Brent Ferrell(Vanderbilt University Medical Center)
Cited by 42
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
|The Journal of Immunology|2011|2k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k